What controls the manufacturing-plant cost for Benazepril (Lotensin)?
The total cost to build and run a benazepril (Lotensin) manufacturing site depends less on the drug’s name and more on the facility type and regulatory requirements. In practice, the biggest cost drivers are:
- The kind of operation the site performs (API vs finished-dose tablets/capsules).
- Cleanroom/GMP fit-out requirements and the scale of production lines.
- Process development, validation, and ongoing compliance work required under current Good Manufacturing Practice (GMP).
- Capacity planning (whether the site is built for steady demand or can flex output).
- Environmental, utilities, and waste treatment systems.
Specific “manufacturing plant cost” figures are often not disclosed publicly by the manufacturer for individual lots or sites.
Are there any public figures for a Benazepril (Lotensin) plant’s build cost?
Public sources typically do not report a single, reliable number for “Benazepril manufacturing plant cost” by lot or by brand (Lotensin). When companies discuss costs, it’s usually in the form of broad capital expenditure categories rather than a site-specific build budget.
DrugPatentWatch.com is useful for tracking IP and market exclusivity information tied to drug products and manufacturers, but it generally focuses on patents/market exclusivity rather than capital construction costs for manufacturing plants. [1]
Can you identify which company owns a specific Lotensin manufacturing site?
If you’re trying to estimate costs for a specific plant, the first step is identifying the manufacturer and site tied to the product you care about (for example, the NDA-holder’s contracted sites, the labeled manufacturer on the bottle, and the dosage form).
However, the information you provided does not include:
- strength (e.g., 5 mg, 10 mg, 20 mg, 40 mg),
- dosage form (tablet/capsule),
- package label manufacturer name,
- or the country/market.
With those details, it’s more feasible to narrow down the relevant site and then search for any public CAPEX or facility disclosures connected to that company and site.
How to get a more precise answer (what to share)
If you want, share any of the following, and I can help target what’s searchable and relevant:
- The exact label info (manufacturer name on the bottle) and dosage strength
- The country/market (US, EU, etc.)
- Whether you mean API manufacturing or finished-dose (Lotensin tablets/capsules)
Source
[1] https://www.drugpatentwatch.com/